Serotyping isolates of Anaplasma phagocytophilum by using monoclonal antibodies

Hisashi Inokuma1, Philippe Brouqui, J Stephen Dumler

  • 1Laboratory of Veterinary Internal Medicine, Faculty of Agriculture, Yamaguchi University, 753-8515 Yamaguchi, Japan.

Insights

Researchers developed ten monoclonal antibodies (MAbs) to characterize Anaplasma phagocytophilum, identifying three distinct serotypes. These MAbs target Msp2 proteins and can differentiate human and animal isolates, aiding in diagnostic tool development.

Area of Science:

  • Immunology
  • Microbiology
  • Veterinary Medicine

Background:

  • Anaplasma phagocytophilum causes human granulocytic ehrlichiosis.
  • Characterizing different isolates is crucial for understanding disease transmission and developing diagnostics.

Purpose of the Study:

  • To develop and characterize monoclonal antibodies (MAbs) for Anaplasma phagocytophilum.
  • To subtype A. phagocytophilum isolates using developed MAbs.

Main Methods:

  • Production of ten mouse monoclonal antibodies (MAbs) against A. phagocytophilum.
  • Subtyping of seven A. phagocytophilum isolates.
  • Western blot analysis to identify MAb targets.

Main Results:

  • MAbs primarily reacted with 41- to 46-kDa Msp2 proteins.
  • Six MAbs recognized all tested isolates.
  • Four MAbs differentiated human isolates from Wisconsin from those in New York and animal isolates, revealing three serotypes.

Conclusions:

  • Developed MAbs are valuable tools for antigenic characterization of A. phagocytophilum.
  • Identification of distinct serotypes aids in understanding isolate diversity.
  • Further development of specific MAbs can enhance diagnostic capabilities.